Delaware Chapter of the American College of Cardiology

Join us for the ACC Delaware Chapter Meeting: ACC by the Sea for engaging live education sessions from local, regional, and national experts with Q&A real-time. The educational meeting includes topics of cardio obstetrics, lipids, amyloid, etc., and a chapter update from our Governor Dr. Vinay Hosmane. Participation in this event will earn CME/CNE/and MOC. We look forward to seeing you (IN-PERSON) October 25 – 27, 2024!

For more Information and Register: Delaware ACC By the Sea: 2024 Chapter Meeting

Delaware Chapter of the American College of Cardiology

Our purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments.

ACC Live Courses

For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

Latest in Cardiology from ACC.org

Renuka Jain, MD, FACC, Named Next BOG Chair-Elect
The ACC has named Renuka Jain, MD, FACC, as the incoming chair-elect of its Board of Governors, beginning April 2025 following ACC.25 in Chicago, IL. She will replace David E. Winchester, MD, MS, FACC, as BOG Chair for 2026 to 2027.
Team-Based Care of Women With CVD From the Preconception Through Postpartum Periods: Optimizing Preconception Cardiometabolic Conditions
Cardiovascular disease (CVD) has been the leading cause of maternal death in the United States, with increasing rates over the past decades due to factors such as advancing age and increased CVD risk factors.
Older Patients With NSTEMI Randomized Interventional Treatment: SENIOR-RITA Trial
In this interview, Drs. Nanette Kass Wenger and Vijay Kunadian discuss the SENIOR RITA trial results and the importance of individualizing routine invasive therapy in individuals â‰¥75 years of age.
Safety, Efficacy, and Quantitative Understanding of Obstruction Impact of Aficamten in HCM
The goal of the SEQUOIA-HCM trial was to compare the safety and efficacy of aficamten compared with placebo among patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM).
Chronic Use of Amiodarone Against Implantable Cardioverter-Defibrillator Therapy for Primary Prevention of Death in Patients With Chagas Cardiomyopathy Study
The goal of the CHAGASICS trial was to evaluate implantable cardioverter-defibrillators (ICDs) compared with amiodarone among patients with chronic Chagas cardiomyopathy.